SRDX
Price
$38.15
Change
-$0.02 (-0.05%)
Updated
Nov 14, 03:29 PM (EDT)
77 days until earnings call
VNRX
Price
$0.73
Change
-$0.03 (-3.95%)
Updated
Nov 14, 03:37 PM (EDT)
One day until earnings call
Ad is loading...

SRDX vs VNRX

Header iconSRDX vs VNRX Comparison
Open Charts SRDX vs VNRXBanner chart's image
Surmodics
Price$38.15
Change-$0.02 (-0.05%)
Volume$100
CapitalizationN/A
VolitionRX
Price$0.73
Change-$0.03 (-3.95%)
Volume$100
CapitalizationN/A
SRDX vs VNRX Comparison Chart
Loading...
SRDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VNRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
SRDX vs. VNRX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SRDX is a Buy and VNRX is a Hold.

COMPARISON
Comparison
Nov 14, 2024
Stock price -- (SRDX: $38.20 vs. VNRX: $0.76)
Brand notoriety: SRDX and VNRX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: SRDX: 27% vs. VNRX: 178%
Market capitalization -- SRDX: $397.04M vs. VNRX: $62.13M
SRDX [@Medical Specialties] is valued at $397.04M. VNRX’s [@Medical Specialties] market capitalization is $62.13M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SRDX’s FA Score shows that 0 FA rating(s) are green whileVNRX’s FA Score has 0 green FA rating(s).

  • SRDX’s FA Score: 0 green, 5 red.
  • VNRX’s FA Score: 0 green, 5 red.
According to our system of comparison, VNRX is a better buy in the long-term than SRDX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SRDX’s TA Score shows that 5 TA indicator(s) are bullish while VNRX’s TA Score has 6 bullish TA indicator(s).

  • SRDX’s TA Score: 5 bullish, 4 bearish.
  • VNRX’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, VNRX is a better buy in the short-term than SRDX.

Price Growth

SRDX (@Medical Specialties) experienced а -0.75% price change this week, while VNRX (@Medical Specialties) price change was +26.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.85%. For the same industry, the average monthly price growth was +1.00%, and the average quarterly price growth was -4.44%.

Reported Earning Dates

SRDX is expected to report earnings on Jan 30, 2025.

VNRX is expected to report earnings on Mar 12, 2025.

Industries' Descriptions

@Medical Specialties (-1.85% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SRDX($397M) has a higher market cap than VNRX($62.1M). VNRX YTD gains are higher at: 6.555 vs. SRDX (5.089). SRDX has higher annual earnings (EBITDA): 22.1M vs. VNRX (-34.04M). SRDX has more cash in the bank: 35.2M vs. VNRX (20.7M). VNRX has less debt than SRDX: VNRX (5.86M) vs SRDX (33.9M). SRDX has higher revenues than VNRX: SRDX (138M) vs VNRX (775K).
SRDXVNRXSRDX / VNRX
Capitalization397M62.1M639%
EBITDA22.1M-34.04M-65%
Gain YTD5.0896.55578%
P/E Ratio71.51N/A-
Revenue138M775K17,806%
Total Cash35.2M20.7M170%
Total Debt33.9M5.86M579%
FUNDAMENTALS RATINGS
SRDX vs VNRX: Fundamental Ratings
SRDX
VNRX
OUTLOOK RATING
1..100
622
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
55
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
88100
PRICE GROWTH RATING
1..100
5147
P/E GROWTH RATING
1..100
94100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

VNRX's Valuation (55) in the Medical Or Nursing Services industry is somewhat better than the same rating for SRDX (91) in the Medical Specialties industry. This means that VNRX’s stock grew somewhat faster than SRDX’s over the last 12 months.

VNRX's Profit vs Risk Rating (100) in the Medical Or Nursing Services industry is in the same range as SRDX (100) in the Medical Specialties industry. This means that VNRX’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's SMR Rating (88) in the Medical Specialties industry is in the same range as VNRX (100) in the Medical Or Nursing Services industry. This means that SRDX’s stock grew similarly to VNRX’s over the last 12 months.

VNRX's Price Growth Rating (47) in the Medical Or Nursing Services industry is in the same range as SRDX (51) in the Medical Specialties industry. This means that VNRX’s stock grew similarly to SRDX’s over the last 12 months.

SRDX's P/E Growth Rating (94) in the Medical Specialties industry is in the same range as VNRX (100) in the Medical Or Nursing Services industry. This means that SRDX’s stock grew similarly to VNRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SRDXVNRX
RSI
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 16 days ago
70%
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
51%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
SRDX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VNRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OEGYX36.550.03
+0.08%
Invesco Discovery Mid Cap Growth Y
GLPSX38.56N/A
N/A
Goldman Sachs MLP Energy Infras R6
DALCX28.83-0.04
-0.14%
Dean Mid Cap Value
NSFMX13.18-0.03
-0.23%
Natixis Target Retirement 2060 N
FHJVX35.74-0.17
-0.47%
Fidelity Advisor Europe M

SRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRDX has been loosely correlated with LIVN. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if SRDX jumps, then LIVN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
-0.93%
LIVN - SRDX
40%
Loosely correlated
+1.08%
RMD - SRDX
32%
Poorly correlated
-4.76%
TMDX - SRDX
31%
Poorly correlated
+1.49%
UFPT - SRDX
29%
Poorly correlated
-8.37%
CTKB - SRDX
28%
Poorly correlated
-3.69%
More

VNRX and

Correlation & Price change

A.I.dvisor tells us that VNRX and SRDX have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VNRX and SRDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNRX
1D Price
Change %
VNRX100%
+2.14%
SRDX - VNRX
25%
Poorly correlated
-0.93%
VAPO - VNRX
25%
Poorly correlated
N/A
GENE - VNRX
23%
Poorly correlated
N/A
RMD - VNRX
23%
Poorly correlated
-4.76%
MASI - VNRX
23%
Poorly correlated
+0.52%
More